Evidence map›Paper›PMID 28344646›Full record

ArticleBiotechnology for biofuels2017

Comparative insights into the saccharification potentials of a relatively unexplored but robust

Funso Emmanuel Ogunmolu, Navya Bhatt Kammachi Jagadeesha, Rakesh Kumar, Pawan Kumar, Dinesh Gupta, Syed Shams Yazdani

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Profiling of the β-glucosidases identified in the genome ofApplied and environmental microbiology · 2023
    Article
  4. Article
  5. Genome editing inSTAR protocols · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Funso Emmanuel OgunmoluMicrobial Engineering Group, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067 India.
Navya Bhatt Kammachi JagadeeshaMicrobial Engineering Group, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067 India.
Rakesh KumarTranslational Bioinformatics Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Pawan KumarTranslational Bioinformatics Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Dinesh GuptaTranslational Bioinformatics Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Syed Shams YazdaniMicrobial Engineering Group, International Centre for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi, 110067 India.ORCID 0000-0002-6558-4612
International Centre for Genetic Engineering and Biotechnology · INCentre for Advanced Bioenergy Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGH7 cellobiohydrolases (CBH1) are vital for the breakdown of cellulose. We had previously observed the enzyme as the most dominant protein in the active cellulose-hydrolyzing secretome of the hypercellulolytic ascomycete-

resultsThere were marginal differences observed in the stability of both enzymes, with

conclusionTo the best of our knowledge, this is the first report about a comprehensive and comparative description of CBH1 from hypercellulolytic ascomycete-

Indexed as

Biomass degradationCAZymes: glycoside hydrolases: Penicillium funiculosumCellobiohydrolase 1Molecular dynamics

Identifiers

PMID28344646
PMCPMC5360062
OpenAlexW2599597434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.